#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia beta Gastrooesophageal cancer Acute graft versus host disease Urea cycle disorder Ornithine transcarbamoylase deficiency Pleural mesothelioma malignant Cardiac arrest Infertility male Oesophageal achalasia Stiff person syndrome Henoch-Schonlein purpura Hypochromic anaemia Anal fistula Ocular lymphoma Cardiac amyloidosis More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome Atypical haemolytic uraemic syndrome Ewing’s sarcoma metastatic – Basic Information Angiosarcoma recurrent Pelizaeus-Merzbacher disease – Trials in Disease Usher’s syndrome – Life with Disease Lymphangioma Usher’s syndrome Ornithine transcarbamoylase deficiency – Life with Disease Metachromatic leukodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inaxaplin Alxn2220 Cls12311 Antipsychotics ZALFERMIN Leriglitazone Treprostinil Sodium Atl001 Etravirine Talazoparib Everolimus Neflamapimod Mexiletine Hydrochloride F1245/05 VOXVOGANAN Riluzole Dapansutrile Atezolizumab Nifedipine Minocycline Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Follicular lymphoma stage II Vesicoureteric reflux Chronic spontaneous urticaria Juvenile psoriatic arthritis Bladder cancer Stomatitis Cutaneous lupus erythematosus Chronic myeloid leukaemia Renal cancer recurrent Open angle glaucoma Mesothelioma malignant Drug dependence C3 glomerulopathy Metastases to rectum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic coronary syndrome

  • Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    Poland

  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium Italy Luxembourg Spain

  • Study on the Safety and Effectiveness of Short Dual Antiplatelet Therapy with Ticagrelor, Clopidogrel, and Prasugrel in Patients Aged 65+ with Coronary Artery Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Prasugrel
    • Clopidogrel
    France

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial flutter
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    • Apixaban
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on Adjusting Clopidogrel and Prasugrel Dosage for Patients with Chronic Coronary Syndrome Based on Body Weight

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    The Netherlands

  • Study on Edoxaban for Patients with Atrial Fibrillation and Coronary Syndrome Undergoing PCI

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Acute coronary syndrome
    • Atrial fibrillation
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium Denmark Italy The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!